Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Marianna, Silletta"'
Autor:
Margherita Rimini, Margarida Montes, Elisabeth Amadeo, Francesco Vitiello, Masatoshi Kudo, Toshifumi Tada, Goki Suda, Shigeo Shimose, Sara Lonardi, Fabian Finkelmeier, Francesca Salani, Lorenzo Antonuzzo, Fabio Marra, Massimo Iavarone, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Rodolfo Sacco, Ilario Giovanni Rapposelli, Mario Scartozzi, Pella Nicoletta, Luca Aldrighetti, Mara Persano, Silvia Camera, Federico Rossari, Silvia Foti, Takashi Kumada, Atsushi Hiraoka, Hideki Iwamoto, Mario Domenico Rizzato, Vera Himmelsbach, Gianluca Masi, Mattia Corradi, Ciro Celsa, Conti Fabio, Giovanni Luca Frassineti, Stefano Cascinu, Andrea Casadei-Gardini, Jose Presa
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Recently, in Hepatocellular carcinoma (HCC) setting, the use of metformin has been associated to a trend toward worse response rate, overall survival and progression free survival in patients who received immunotherapy. The study population
Externí odkaz:
https://doaj.org/article/41799d524b5a43689733a5a5474189a2
Autor:
Lorenz Balcar, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Katharina Pomej, Marta Bofill Roig, Elias Laurin Meyer, Jaekyung Che, Naoshi Nishida, Pei-Chang Lee, Linda Wu, Celina Ang, Anja Krall, Anwaar Saeed, Bernardo Stefanini, Antonella Cammarota, Tiziana Pressiani, Yehia I. Abugabal, Shadi Chamseddine, Brooke Wietharn, Alessandro Parisi, Yi-Hsiang Huang, Samuel Phen, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominik Bettinger, Arndt Vogel, Johann von Felden, Kornelius Schulze, Marianna Silletta, Michael Trauner, Adel Samson, Henning Wege, Fabio Piscaglia, Peter R. Galle, Rudolf Stauber, Masatoshi Kudo, Amit G. Singal, Aleena Itani, Susanna V. Ulahannan, Neehar D. Parikh, Alessio Cortellini, Ahmed Kaseb, Lorenza Rimassa, Hong Jae Chon, David J. Pinato, Matthias Pinter
Publikováno v:
JHEP Reports, Vol 6, Iss 2, Pp 100982- (2024)
Background & Aims: Sex-related differences in the immune pathogenesis of hepatocellular carcinoma (HCC), particularly related to oestrogen-dependent secretion of pro-tumourigenic cytokines, are well-known. Whether sex influences the efficacy and safe
Externí odkaz:
https://doaj.org/article/a0a6b9404c43458295dafe7f3cb32ed2
Autor:
Claudia Angela Maria Fulgenzi, Bernhard Scheiner, James Korolewicz, Charalampos-Vlasios Stikas, Alessandra Gennari, Bruno Vincenzi, Mark R. Openshaw, Marianna Silletta, Matthias Pinter, Alessio Cortellini, Lorenza Scotti, Antonio D’Alessio, David J. Pinato
Publikováno v:
JHEP Reports, Vol 5, Iss 5, Pp 100702- (2023)
Background & Aims: Direct comparisons across first-line regimens for advanced hepatocellular carcinoma are not available. We performed a network metanalysis of phase III of trials to compare first-line systemic treatments for hepatocellular carcinoma
Externí odkaz:
https://doaj.org/article/da5bfd6a88df4c8ca1113b3b4099192a
Autor:
Claudia Angela Maria Fulgenzi, Andrea Napolitano, Eliodoro Faiella, Laura Messina, Gennaro Castiello, Flavia Paternostro, Marianna Silletta, Francesco Pantano, Giuseppe Tonini, Daniele Santini, Bruno Vincenzi
Publikováno v:
Journal of Bone Oncology, Vol 34, Iss , Pp 100422- (2022)
Adjuvant treatment with Imatinib is the standard of care for high-risk resected GISTs. Imatinib is known to have an impact on bone mineral density in patients affected by chronic myeloid leukemia, however this effect has never been investigated in GI
Externí odkaz:
https://doaj.org/article/6b71d272acba46989af605eba6f809c1
LenvatinibVersusSorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis
Autor:
GIOVANNI ANTONIO MARROCCO, MARIANNA SILLETTA, VINCENZO BIANCO, FRANCESCO MONDERA, CAROLINA SCIORTINO, LAURA PAPPALARDO, VALENTINA VIGLIALORO, ENRICO CORTESI, GIUSEPPE TONINI, SALVATORE CAPONNETTO
Publikováno v:
Anticancer Research. 43:755-763
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe20007c532e7722d5ec209e0bc0620d
https://doi.org/10.21873/anticanres.16215
https://doi.org/10.21873/anticanres.16215
Autor:
Francesco Caputo, Vincenzo Dadduzio, Francesco Tovoli, Giulia Bertolini, Giuseppe Cabibbo, Krisida Cerma, Caterina Vivaldi, Luca Faloppi, Mario Domenico Rizzato, Fabio Piscaglia, Ciro Celsa, Lorenzo Fornaro, Giorgia Marisi, Fabio Conti, Nicola Silvestris, Marianna Silletta, Sara Lonardi, Alessandro Granito, Caterina Stornello, Valentina Massa, Giorgio Astara, Sabina Delcuratolo, Stefano Cascinu, Mario Scartozzi, Andrea Casadei-Gardini
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0232449 (2020)
BACKGROUND AND AIMS:The present study aims to investigate the role of the prognostic nutritional index (PNI) on survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib. METHODS:This multicentric study included a train
Externí odkaz:
https://doaj.org/article/574a3b3c1a624653a2b3f7e78e7be113
Autor:
Alessandro Mazzocca, Andrea Napolitano, Marianna Silletta, Mariella Spalato Ceruso, Daniele Santini, Giuseppe Tonini, Bruno Vincenzi
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
The tyrosine kinase inhibitor (TKI) imatinib has radically changed the natural history of KIT-driven gastrointestinal stromal tumours (GISTs). Approved second-line and third-line medical therapies are represented by the TKIs sunitinib and regorafenib
Externí odkaz:
https://doaj.org/article/663f874373cf4b51aa344922b9ce7349
Autor:
Valentina Burgio, Massimo Iavarone, Giovan Giuseppe Di Costanzo, Fabio Marra, Sara Lonardi, Emiliano Tamburini, Fabio Piscaglia, Gianluca Masi, Ciro Celsa, Francesco Giuseppe Foschi, Marianna Silletta, Daniela Caterina Amoruso, Margherita Rimini, Mariangela Bruccoleri, Raffaella Tortora, Claudia Campani, Caterina Soldà, Massimo Giuseppe Viola, Antonella Forgione, Fabio Conti, Francesca Salani, Silvia Catanese, Carmelo Marco Giacchetto, Claudia Angela Maria Fulgenzi, Carmine Coppola, Pietro Lampertico, Antonio Pellino, Gabriele Rancatore, Giuseppe Cabibbo, Francesca Ratti, Federica Pedica, Angelo Della Corte, Massimo Colombo, Francesco De Cobelli, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini
Publikováno v:
Cancer Management and Research, Vol Volume 13, Pp 9379-9389 (2021)
Cancer Management and Research
Cancer Management and Research
Valentina Burgio,1 Massimo Iavarone,2 Giovanni Giuseppe Di Costanzo,3 Fabio Marra,4 Sara Lonardi,5,6 Emiliano Tamburini,7 Fabio Piscaglia,8 Gianluca Masi,9,10 Ciro Celsa,11 Francesco Giuseppe Foschi,12 Marianna Silletta,13 Daniela Caterina Amoruso,14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::869036421242f17f999f6b357dba8cdd
https://www.dovepress.com/real-life-clinical-data-of-lenvatinib-versus-sorafenib-for-unresectabl-peer-reviewed-fulltext-article-CMAR
https://www.dovepress.com/real-life-clinical-data-of-lenvatinib-versus-sorafenib-for-unresectabl-peer-reviewed-fulltext-article-CMAR
Autor:
Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, Lorenza Rimassa, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Francesco Tovoli, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Tiziana Pressiani, Takumi Kawaguchi, Margarida Montes, Caterina Vivaldi, Caterina Soldà, Fabio Piscaglia, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Massimo Iavarone, Giovanni Di Costanzo, Fabio Marra, Mario Scartozzi, Emiliano Tamburini, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Antonella Cammarota, Valentina Burgio, Stefano Cascinu, Andrea Casadei-Gardini
Purpose: The purpose of this study is to compare response rates of lenvatinib and atezolizumab plus bevacizumab, in first-line real-world setting. Methods: Overall cohort included Western and Eastern hepatocellular carcinoma (HCC) patient populations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c44a7f9afd3ac1d109f57a5526a43ce
https://hdl.handle.net/10447/583022
https://hdl.handle.net/10447/583022
Autor:
Paolo G. Casali, Sebastian Bauer, Alessandro Gronchi, Angelo P. Dei Tos, Robin L. Jones, Axel Le Cesne, Peter Hohenberger, Javier Martin-Broto, Giuseppe Tonini, Marta Sbaraglia, Marianna Silletta, Johanna Falkenhorst, Ingrid M.E. Desar, Hans Gelderblom, Neeltje Steeghs, Nikki S. IJzerman, Winan J. van Houdt, Maria A. Pantaleo, Giuseppe Badalamenti, Tommaso De Pas, Silvia Gasperoni, Antonella Brunello, Giovanni Grignani, Antoine Italiano, Mariella Spalato Ceruso, Margherita Nannini, Nadia Hindi, Spyridon Gennatas, Elena Fumagalli, Heikki Joensuu, Peter Reichardt, Jean-Yves Blay, Piotr Rutkowski, Olivier Mir, Marta Fiocco, Andrea Napolitano, Bruno Vincenzi
Purpose:The effect of high-dose imatinib (800 mg/day) on survival in the adjuvant treatment of patients with resected KIT exon 9–mutated gastrointestinal stromal tumors (GIST) is not established. Here, the association of dose and other clinicopatho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48545376b166dd5cba26411f0399e2fb
https://doi.org/10.1158/1078-0432.c.6531227
https://doi.org/10.1158/1078-0432.c.6531227